Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.26M Buy
+43,082
New +$5.35M 0.01% 1025
2026
Q1
– Sell
-12,363
Closed -$1.31M – 3687
2025
Q4
$1.31M Buy
12,363
+2,186
+21% +$221K ﹤0.01% 1557
2025
Q3
$953K Buy
10,177
+6,822
+203% +$634K ﹤0.01% 1543
2025
Q2
$290K Buy
+3,355
New +$281K ﹤0.01% 1858
2024
Q4
– Sell
-26,205
Closed -$2.48M – 2351
2024
Q3
$2.48M Buy
26,205
+4,372
+20% +$382K 0.01% 792
2024
Q2
$1.82M Buy
21,833
+5,418
+33% +$451K 0.01% 774
2024
Q1
$1.41M Buy
+16,415
New +$1.34M 0.01% 719
2023
Q4
– Sell
-18,722
Closed -$1.35M – 2230
2023
Q3
$1.35M Sell
18,722
-40,957
-69% -$3.11M 0.01% 819
2023
Q2
$4.52M Buy
+59,679
New +$4.01M 0.04% 317
2022
Q3
– Sell
-15,859
Closed -$736K – 2706
2022
Q2
$736K Buy
+15,859
New +$831K 0.01% 1165
2021
Q4
– Sell
-20,568
Closed -$1.03M – 3080
2021
Q3
$1.03M Buy
20,568
+8,383
+69% +$434K 0.01% 1240
2021
Q2
$715K Sell
12,185
-23,895
-66% -$1.48M 0.01% 1462
2021
Q1
$2.35M Buy
+36,080
New +$2.22M 0.02% 538
2020
Q4
– Sell
-17,325
Closed -$763K – 1774
2020
Q3
$763K Buy
+17,325
New +$762K 0.02% 696

Other funds holding ACA

HRT Financial's ACA Position: Q2 2026 in Review

HRT Financial opened a new position in Arcosa (ACA) in Q2 2026: 43,082 shares worth $6.26M. The stake represents 0.01% of the portfolio and ranks #1025 among its holdings. This is a return to the name: HRT Financial previously reported a position in ACA as recently as Q4 2025.

HRT Financial first reported a position in ACA in Q3 2020 and has held it in 14 quarters since. 428 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • HRT Financial held 43,082 shares of Arcosa worth $6.26M as of Q2 2026.
  • Arcosa was a new HRT Financial position in Q2 2026.
  • Arcosa made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1025 holding.
  • HRT Financial first reported a position in Arcosa in Q3 2020 and has held it in 14 quarters since.
  • 428 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.